Why is Orexo AB ?
- NET SALES(Q) At SEK 5 MM has Fallen at -92.11%
- PRE-TAX PROFIT(Q) At SEK -104.2 MM has Fallen at -53.07%
- NET PROFIT(Q) At SEK -105.2 MM has Fallen at -52.57%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 20.81%, its profits have risen by 0.9%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Orexo AB for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at SEK 106.8 MM
Higher at SEK -220.8 MM
Highest at 4.6 times
Highest at SEK 1,298.6 MM
At SEK 5 MM has Fallen at -92.11%
At SEK -104.2 MM has Fallen at -53.07%
At SEK -105.2 MM has Fallen at -52.57%
Grown by 320.29% (YoY
Lowest at 1.93 times
Highest at SEK 29.2 MM
Lowest at SEK -74.2 MM
Lowest at SEK -3.81
Here's what is working for Orexo AB
Inventory Turnover Ratio
Operating Cash Flows (SEK MM)
Cash and Cash Equivalents
Here's what is not working for Orexo AB
Net Sales (SEK MM)
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
Interest Paid (SEK MM)
Interest Paid (SEK MM)
Operating Profit (SEK MM)
EPS (SEK)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales






